Yoshino I - Search Results

1

Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas.

Shoji F, Yoshino I, Yano T, Kometani T, Ohba T, Kouso H, Takenaka T, Miura N, Okazaki H, Maehara Y. Shoji F, et al. Among authors: yoshino i. Cancer. 2007 Dec 15;110(12):2793-8. doi: 10.1002/cncr.23101. Cancer. 2007. PMID: 17941001 Free article.

2

Development of a new culture system for human lymphokine-activated killer cells: comparison with a conventional static culture method.

Murata M, Yano T, Yoshino I, Togami M, Sogabe M, Yasumoto K, Sugimachi K, Kimura G, Nomoto K. Murata M, et al. Among authors: yoshino i. Cytotechnology. 1991 Oct;7(2):75-83. doi: 10.1007/BF00350913. Cytotechnology. 1991. PMID: 1367909

3

T lymphocytes bearing gamma/delta-type T-cell receptor in thymic tumor tissues.

Yoshino I, Kimura G, Matzuzaki G, Nomoto K, Ishida T, Sugimachi K, Yano T. Yoshino I, et al. J Natl Cancer Inst. 1992 Nov 18;84(22):1755-6. doi: 10.1093/jnci/84.22.1755. J Natl Cancer Inst. 1992. PMID: 1433361 No abstract available.

4

Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.

Yoshino I, Yano T, Murata M, Ishida T, Sugimachi K, Kimura G, Nomoto K. Yoshino I, et al. Cancer Res. 1992 Feb 15;52(4):775-81. Cancer Res. 1992. PMID: 1737336

5

Oligoclonal T lymphocytes infiltrating human lung cancer tissues.

Yoshino I, Yano T, Yoshikai Y, Murata M, Sugimachi K, Kimura G, Nomoto K. Yoshino I, et al. Int J Cancer. 1991 Mar 12;47(5):654-8. doi: 10.1002/ijc.2910470504. Int J Cancer. 1991. PMID: 1848534

6

A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells. Basis, clinical toxicity, and immunomodulatory effects.

Yano T, Ishida T, Yoshino I, Murata M, Yasumoto K, Kimura G, Nomoto K, Sugimachi K. Yano T, et al. Among authors: yoshino i. Biotherapy. 1991;3(3):245-51. doi: 10.1007/BF02171688. Biotherapy. 1991. PMID: 1854593

7

Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2.

Yoshino I, Yano T, Murata M, Ishida T, Sugimachi K, Kimura G, Nomoto K. Yoshino I, et al. Cancer Res. 1991 Mar 1;51(5):1494-8. Cancer Res. 1991. PMID: 1997188

8

Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage.

Ichinose Y, Yano T, Asoh H, Yokoyama H, Yoshino I, Katsuda Y. Ichinose Y, et al. Among authors: yoshino i. J Thorac Cardiovasc Surg. 1995 Sep;110(3):601-5. doi: 10.1016/S0022-5223(95)70090-0. J Thorac Cardiovasc Surg. 1995. PMID: 7564425 Free article.

9

Results of a limited resection for compromised or poor-risk patients with clinical stage I non-small cell carcinoma of the lung.

Yano T, Yokoyama H, Yoshino I, Tayama K, Asoh H, Hata K, Ichinose Y. Yano T, et al. Among authors: yoshino i. J Am Coll Surg. 1995 Jul;181(1):33-7. J Am Coll Surg. 1995. PMID: 7599768

10

Phenotypes of lymphocytes infiltrating non-small cell lung cancer tissues and its variation with histological types of cancer.

Yoshino I, Yano T, Murata M, Miyamoto M, Ishida T, Sugimachi K, Kimura G, Nomoto K. Yoshino I, et al. Lung Cancer. 1993 Oct;10(1-2):13-9. doi: 10.1016/0169-5002(93)90305-h. Lung Cancer. 1993. PMID: 8069600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters